Yoda Pharmaceuticals Inc. (TPEX:7829)
Taiwan · Delayed Price · Currency is TWD 45.20
+0.70 (1.57%)
At close: Aug 18, 2026
Yoda Pharmaceuticals Market Cap
Yoda Pharmaceuticals has a market cap or net worth of 3.81 billion as of August 19, 2026. Its market cap has increased by 29.07% in one year.
Market Cap
3.81B
Enterprise Value
2.73B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
45.20
ChartMarket Cap Chart
Since June 3, 2025, Yoda Pharmaceuticals's market cap has increased from 2.92B to 3.81B, an increase of 30.47%. That is a compound annual growth rate of 24.63%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 18, 2026 | 3.81B | -18.18% |
| Dec 31, 2025 | 4.65B | 59.46% |
| Jun 3, 2025 | 2.92B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Orient Pharma | 5.34B |
| Panion & Bf Biotech | 5.02B |
| Orient EuroPharma | 4.27B |
| LIWANLI Innovation | 3.92B |
| Tien Liang BioTech | 3.81B |
| Easywell Biomedicals | 3.76B |
| Maywufa Company | 2.78B |
| Merdury Biopharmaceutical | 2.54B |